CVE:HIV

HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HIV stock logo

About HIVE Blockchain Technologies Stock (CVE:HIV)

HIV Stock News Headlines

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
HIVE Apr 2024 1.000 call
See More Headlines
Receive HIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/12/2024
Today
5/07/2024
Next Earnings (Estimated)
7/04/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

HIV Stock Analysis - Frequently Asked Questions

Should I buy or sell HIVE Blockchain Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HIVE Blockchain Technologies in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HIV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HIV, but not buy additional shares or sell existing shares.
View HIV analyst ratings
or view top-rated stocks.

When is HIVE Blockchain Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our HIV earnings forecast
.

How were HIVE Blockchain Technologies' earnings last quarter?

HIVE Blockchain Technologies Ltd. (CVE:HIV) posted its earnings results on Monday, February, 12th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.05. The firm earned $42.55 million during the quarter, compared to analysts' expectations of $32.35 million.

How do I buy shares of HIVE Blockchain Technologies?

Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:HIV) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners